Kymera Therapeutics Announces $102 Million Financing
- Posted by ISPE Boston
- On March 17, 2020
Kymera Therapeutics has announced the closing of a $102 million Series C financing round. was led by Biotechnology Value Fund (BVF) and Redmile Group. Kymera also received a strategic investment from The Leukemia & Lymphoma Society‘s Therapy Acceleration Program directed toward advancing the company’s work to treat blood-based cancers. “We are very excited to be […]
Read More